SLC6A3 and attention deficit-hyperactivity disorder: DAT is specifically expressed in the presynaptic region of dopaminergic neurons and has been the focus of numerous studies on dopamine‐related diseases, including ADHD, not only because of its vital role in dopaminergic neurotransmission but also because the blockage of DAT serves as a therapeutic target for ADHD.